Diagnostic marker and application thereof in COVID-19 diagnosis and coronavirus previous infection detection
A technology of COVID-19 and COVID19-V004, applied in the field of biomedicine, can solve the problems of difficulty in protein structure expression, difficult to stably preserve, increase the difficulty of protein expression and purification, etc., and achieve the effect of easy operation.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0068] Example 1 Detection of serum serum with COVID-19 rehabilitation patients using a small peptide chip
[0069] 1. Processing and coupling of peptides
[0070] 1.1 Preparation: According to 12AA per peptide, there is a total of 6AA overlapping lengths, and the S protein has a total of 220 peptides. The S1 region contains 118 peptides, and the S2 region includes 102 peptides, including the peptide nraltgiaveqd and IAVEQDKNTQEV in the present invention, which is finally synthesized and purified by Gil Biochemical (Shanghai) Co., Ltd., and the N-terminal of each peptide after purification. Cys is coupled to BSA, co-coupling successful 197 (coupling products).
[0071] The specific coupling steps are as follows:
[0072] 1 Take 10 mg of BSA is dissolved in 1 mlpbs buffer, the concentration is 10 mg / ml.
[0073] 2 Take 10 μl of SMCC (preferably 1 mg SMCC is dissolved in 10 μLDMSO) is dissolved in a BSA solution, and 1 h is placed at 25 ° C.
[0074] 3 Transfer the activated BSA-...
Embodiment 2
[0147] 1, and coupling the peptide processing
[0148] Peptide COVID19-V004 (amino acid sequence: NRALTGIAVEQDKNTQEV) of GL Biochem (Shanghai) Co., synthesized and purified, together with the N-terminal Cys conjugated to the BSA, to obtain the coupling product. DETAILED same coupling procedure as in Example 1.
[0149] 2, ELISA validation peptide
[0150] Carried out using the method (step 2.3) the same as in Example 1.
PUM
| Property | Measurement | Unit |
|---|---|---|
| concentration | aaaaa | aaaaa |
| Sensitivity | aaaaa | aaaaa |
| Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


